SARS CoV 2 News and Research

RSS

Study shows an inflammatory response in the mice brain is responsible for severe COVID-19

Researchers demonstrated that neuroinvasion and encephalitis caused by SARS-CoV-2 is associated with significant mortality in a special mouse model.

17 Dec 2020

Slower drill rotation during dental procedures can reduce COVID-19 spread

Dental procedures can pose a high risk of viral transmission because the tools that are used often produce aerosols, which can contain high numbers SARS-CoV-2 virions, copies of the virus causing COVID-19.

17 Dec 2020

Natural changes in UV influence the spread of COVID-19, shows study

Natural variations in ultraviolet radiation influence the spread of COVID-19, but the influence is modest compared to preventive measures such as physical distancing, mask wearing, and quarantine, according to new research from Harvard University.

17 Dec 2020

Specific genetic target could help explain the variation in COVID-19 effects

The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has identified a specific genetic target that could help explain the tremendous variation in how sick those infected with COVID-19 become.

17 Dec 2020

COVID-19 spread is linked to atmospheric pollutants exposure

The spread of SARS-CoV-2, the coronavirus responsible for the current pandemic outbreak, has been speculated to be linked to short-term and long-term atmospheric pollutants exposure, mainly particulate matters (PMs).

17 Dec 2020

Researchers examine proteins involved in SARS-CoV-2 infection

Like all viruses, the novel coronavirus is dependent on help from the human host cell. Proteins are the functional units of the cell and enable the virus to enter the host cell or help the virus to replicate.

17 Dec 2020

New study to evaluate health outcomes of SARS-CoV-2 infection in children

An observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV-2 infection in children, including multisystem inflammatory syndrome in children (MIS-C), and to characterize the immunologic pathways associated with different disease presentations and outcomes. SARS-CoV-2 is the virus that causes COVID-19.

16 Dec 2020

Potency of neutralizing antibodies predicts COVID-19 severity and survival

Understanding the body's immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.

16 Dec 2020

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

What does SARS-CoV-2, the virus that causes COVID-19, do once it enters a person's airways, and how does infection in lung cells affect patients' immune responses?

16 Dec 2020

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

Today, the U.S. Food and Drug Administration issued a new emergency use authorization (EUA) for the BinaxNOW COVID-19 Ag Card Home Test which is authorized for use by patients at home with a prescription.

16 Dec 2020

Mass testing is not a ‘silver bullet’ for managing SARS-CoV-2 transmission, say researchers

A team of researchers from various institutions in France recently used a mathematical model to assess the impact of mass testing in controlling the SARS-CoV-2 epidemic. They evaluated the potential impact of mass testing campaigns in an epidemic rebound scenario at the end of the ongoing lockdown in Metropolitan France.

16 Dec 2020

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

As researchers continue to search for antivirals to counter COVID-19, a study presents the potential utility of a decoction called Respiratory Detox Shot (RDS).

16 Dec 2020

Azithromycin trial fails to provide evidence of benefit in COVID-19

Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.

16 Dec 2020

Survey suggests COVID-19 vaccine hesitancy stems from a distrust in the vaccine development and approval process

Survey results of COVID-19 vaccine hesitancy suggest that people are less likely to get the COVID-19 vaccine than the number of people who got the flu shot.

16 Dec 2020

Copper gluconate supplementation could reduce SARS-CoV-2 infection in vitro

The second wave of COVID-19 has affected many countries, costing thousands of lives and dealing further heavy blows to already reeling economies.

16 Dec 2020

Autoimmune condition biomarkers promote SARS-CoV-2 viral entry, study finds

Researchers have reported that the autoimmune PTPN2 risk variant rs1893217 promotes the expression of the SARS-CoV-2 receptor, ACE2, and thus promotes cellular entry, which is mediated by SARS-CoV-2 spike S protein.

16 Dec 2020

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

A new study reveals that the genome of SARS-CoV-2 is inserted into the human genome, accounting for the detection of viral RNAs.

16 Dec 2020

Methylene blue and light inactivates SARS-CoV-2 on N95 respirators and masks, study finds

Researchers at the University of Washington show that methylene blue (MB) and light can decontaminate masks and respirators by inactivating three tested coronaviruses without compromising integrity. The method is effective, low-cost, and does not require specialized equipment, making it applicable in any setting.

16 Dec 2020

Clearer information and increased support may improve compliance with COVID-19 guidelines, says study

UK-based researchers have found that providing clear information and practical or financial support could reduce the number of people who feel that they have to break lockdown rules. They have also evaluated the risk tied to engaging in a particular behavior.

16 Dec 2020

CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients

CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with the University of Melbourne, focused on respiratory therapies for recovering COVID-19 patients.

From AXT Pty Ltd 16 Dec 2020

SARS CoV 2 News and Research

Study shows an inflammatory response in the mice brain is responsible for severe COVID-19

Slower drill rotation during dental procedures can reduce COVID-19 spread

Natural changes in UV influence the spread of COVID-19, shows study

Specific genetic target could help explain the variation in COVID-19 effects

COVID-19 spread is linked to atmospheric pollutants exposure

Researchers examine proteins involved in SARS-CoV-2 infection

New study to evaluate health outcomes of SARS-CoV-2 infection in children

Potency of neutralizing antibodies predicts COVID-19 severity and survival

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

Mass testing is not a ‘silver bullet’ for managing SARS-CoV-2 transmission, say researchers

Traditional herbal medicine Respiratory Detox Shot (RDS) inhibits SARS-CoV, SARS-CoV-2 and Influenza A infection in vitro

Azithromycin trial fails to provide evidence of benefit in COVID-19

Survey suggests COVID-19 vaccine hesitancy stems from a distrust in the vaccine development and approval process

Copper gluconate supplementation could reduce SARS-CoV-2 infection in vitro

Autoimmune condition biomarkers promote SARS-CoV-2 viral entry, study finds

SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome

Methylene blue and light inactivates SARS-CoV-2 on N95 respirators and masks, study finds

Clearer information and increased support may improve compliance with COVID-19 guidelines, says study

CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News